乳房与卵巢手术联合实施增加并发症
该回顾性研究分析145例女性患者,其中87例接受乳房手术与输卵管卵巢切除术联合实施,58例分期分别实施。联合手术组乳房手术相关总体并发症、感染和伤口延迟愈合发生率均更高,组织扩张器乳房再造联合卵巢手术者住院时间更长。多因素logistic回归证实联合手术与术后总体并发症显著相关(OR 5.87)。
要点
- 联合乳房与卵巢手术者乳房手术相关总体并发症发生率为46.5%,分期手术者为19%(p<0.001)。
- 联合手术组感染发生率为22.2%,分期手术组为8.6%(p<0.05);伤口延迟愈合为13.2%对0%(p<0.05)。
- 组织扩张器乳房再造联合卵巢手术者住院3.5天,分期手术者为1.8天(p<0.001)。
核心结论
- 作者数据表明,联合乳房与卵巢手术与乳房手术相关术后并发症风险升高相关,并延长组织扩张器乳房再造患者的住院时间。
- 该研究为考虑同时接受乳房和卵巢手术的患者术前咨询提供了有价值的信息。
研究设计与样本
- 回顾性分析145例女性患者的手术并发症和住院时间,其中87例接受乳房手术与输卵管卵巢切除术联合实施,58例分期分别实施。
- 采用多因素logistic回归模型计算比值比(OR)和95%置信区间(CI)。
- 证据等级为治疗性,III级。
主要发现
- 联合乳房与卵巢手术组乳房手术相关总体并发症发生率为46.5%,分期手术组为19%(p<0.001)。
- 联合手术组感染发生率为22.2%,分期手术组为8.6%(p<0.05)。
- 联合手术组伤口延迟愈合发生率为13.2%,分期手术组为0%(p<0.05)。
- 多因素logistic回归分析证实联合手术与术后总体并发症显著相关(OR 5.87;95%CI 2.03至16.91;p=0.02)。
- 接受组织扩张器乳房再造联合卵巢手术的患者住院时间显著长于分期手术患者(3.5天对1.8天;p<0.001)。
临床怎么用
- 作者认为该研究为考虑同时接受乳房和卵巢手术的患者术前咨询提供了有价值的信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast cancer resulting from a genetic mutations, such as BRCA1 or BRCA2, is seen in 5 to 10 percent of patients. More widespread genetic testing has increased the number of affected women undergoing prophylactic mastectomy and oophorectomy. Recent studies have yielded mixed results regarding complication rates after combined breast and ovarian operations. The authors compared surgical outcomes of breast operations performed in combination with salpingo-oophorectomies or as separate procedures. METHODS: The authors retrospectively analyzed surgical complications and length of hospital stay in 145 female patients, from which 87 had undergone combined breast surgery and salpingo-oophorectomy, and 58 had undergone these procedures separately. Multivariate logistic regression models were used to calculate odds ratios and 95 percent confidence intervals. RESULTS: Patients undergoing combined breast and ovarian operations experienced higher rates of overall complications (46.5 percent versus 19 percent; p < 0.001), infections (22.2 percent versus 8.6 percent; p < 0.05), and delayed wound healing (13.2 percent versus 0 percent; p < 0.05) related to the breast surgery, when compared with patients undergoing separate procedures. Multivariate logistic regression analysis confirmed a significant association between combined surgery and overall postoperative complications (OR, 5.87; 95 percent CI, 2.03 to 16.91; p = 0.02). Patients undergoing tissue expander-based breast reconstruction combined with ovarian surgery had significantly longer hospital stays compared to patients undergoing separate procedures (3.5 days versus 1.8 days; p < 0.001). CONCLUSIONS: The authors' data indicate that combining breast and ovarian operations is associated with a higher risk of postoperative complications related to the breast procedure and increases the duration of hospital stay in patients with tissue expander-based reconstructions. The authors' study provides valuable information for preoperative counseling of patients considering both breast and ovarian surgery. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Henn D, Barrera JA, Sivaraj D, et al. Combining Breast and Ovarian Operations Increases Complications. Plast Reconstr Surg. 2022. PMID: 35245249. doi:10.1097/PRS.0000000000008984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。